Press Releases

 Filter by Provider

Sekur Establishes Foothold in Defense, Intelligence & Special Operations Communications - Deploys SekurVoice for CUI-Compliant Encrypted Voice, and Attends SOF Week 2026 to Engage SOCOM and Defense Contractor Ecosystem

TAMPA, FL / ACCESS Newswire / May 8, 2026 / Marquis Who's Who is proud to honor Paula Bland, Florida Registered Paralegal and owner of Freelance of Tampa LLC, for her distinguished contributions to law and paralegal services. Ms. Bland has built her career on reliability, perseverance and professional versatility, demonstrating a deep commitment to leaving every workplace and working relationship on good terms. Through its recognition of Ms. Bland, Marquis Who's Who celebrates a professional whose dedication continues to strengthen the legal teams and communities she serves.

HILLSIDE, NJ / ACCESS Newswire / May 8, 2026 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2026.

Independent community supporting MBA students and searchers expands rankings beyond investors to cover law firms, due diligence providers, and brokers

Douglas Elliman Inc. (“Douglas Elliman” or the “Company”) (NYSE: DOUG) the parent company of Douglas Elliman Realty, one of the nation's premier luxury residential real estate brokerages, today announced financial results for the three months ended March 31, 2026.

American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today it will release its financial results as of, and for the first quarter ended March 31, 2026, on Friday May 15, 2026, before the New York Stock Exchange open.

Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced the presentation of initial clinical data from the first participant dosed in its Phase 1/2 trial of EN-374 for the treatment of X-linked chronic granulomatous disease (X-CGD) at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting, taking place May 11-15 in Boston. The data represent the first reported clinical experience with in vivo hematopoietic stem cell (HSC)-directed therapy, from which the patient has the potential to create a continuous source of therapeutic immune and blood cells to treat disease.

ESAB Corporation (“ESAB” or the “Company”) (NYSE: ESAB), a focused premier industrial compounder, announced today that its Board of Directors has declared an increased quarterly cash dividend of $0.12 per share of the Company’s common stock. The dividend is payable on July 17, 2026 to shareholders of record as of July 3, 2026.

Janus Henderson Group plc (NYSE: JHG; “JHG," "Janus Henderson,” or the “Company”) published its first quarter 2026 results for the period ended March 31, 2026. First quarter 2026 operating income was US$113.9 million compared to US$487.4 million in the fourth quarter 2025 and US$153.6 million in the first quarter 2025. Adjusted operating income, adjusted for one-time, acquisition and transaction related costs, was US$170.8 million in the first quarter 2026 compared to US$383.7 million in the fourth quarter 2025 and US$156.6 million in the first quarter 2025.

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, announces that its Annual Meeting of Shareholders will be held virtually at 9:00 am PDT on Monday, June 29, 2026. After the meeting materials are finalized and filed with the Securities and Exchanges Commission, such materials will be mailed to shareholders.

~ Total Assets of $2.2 Billion and Over $2 Billion in Financial Assets* ~

CAMBRIDGE, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today announced that it will report financial results for the first quarter ended March 31, 2026, before the market opens on Friday, May 15, 2026.

BERKELEY, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced that first-in-primate data from its proprietary in vivo CAR T cell platform have been accepted as a late-breaking abstract for oral presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting, taking place May 11 – 15, 2026 in Boston, Massachusetts.

Kfar Saba, Israel, May 08, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced it has received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEX: 0800), a global leader in autonomous driving technology, today announced that it will hold an annual general meeting of the Company’s shareholders (the “AGM”) at 10:00 a.m., Beijing time, on Friday, June 26, 2026 at 16/F, Tower A, KWG Flourishing Biotech Square, 68 Luoxuan Boulevard, Guangzhou International Biotech Island, Huangpu District, Guangzhou, Guangdong Province, PRC, for the purposes of considering and, if thought fit, passing each of the Proposed Resolutions as defined and set forth in the notice of the AGM (the “AGM Notice”). A circular of the Company dated May 8, 2026 in relation to the AGM, the AGM Notice and the form of proxy for the AGM are available on the Company’s website at www.weride.ai. The board of directors of the Company fully supports the Proposed Resolutions and recommends that shareholders and holders of the Company’s American depositary shares (“ADSs”) vote in favor of the Proposed Resolutions.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Gemini (GEMI) To Contact Him Directly To Discuss Their Options

Former Los Angeles-based football athlete Therrian Fontenot highlights the role of discipline, structure, and community support in shaping young lives

A recent federal decision to reclassify medical cannabis is reshaping the outlook for licensed operators, prompting renewed attention from businesses and regulators across the country.

A recent federal decision to reclassify medical cannabis is reshaping the outlook for licensed operators, prompting renewed attention from businesses and regulators across the country.

Recommendations aim to help provide clearer safety information for use during pregnancy

VIRGINIA BEACH, VA / ACCESS Newswire / May 8, 2026 / Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) (the "Company") announced today that it has reported its financial and operating results for the three months ended March 31, 2026 with the filing of its Quarterly Report on Form 10-Q (the "Form 10-Q") with the Securities and Exchange Commission. In addition, the Company has posted supplemental information to its website regarding its financial and operating results for the three months ended March 31, 2026. Both the Form 10-Q and the supplemental information can be accessed by visiting the Company's investor relations website at https://ir.whlr.us/.

MINNETONKA, Minn., May 08, 2026 (GLOBE NEWSWIRE) -- On May 8, 2026, the Board of Directors of Table Trac Inc. (the “Company”) (OTCQX: TBTC) approved a cash dividend on the Company’s common stock of $0.02 per share. The dividend is payable on June 12, 2026, to shareholders of record at the close of business on May 29, 2026.

Phil Carrick has released a free Google Visibility Checker designed to help local businesses across the UK understand how they appear on Google Search and Google Maps. The tool helps businesses identify visibility issues that may be affecting enquiries, local rankings, and customer trust online.

Sector-Leading Occupancy and Record-Level Tenant Duration of Stay Driven by Continued Operational Excellence

DWS Municipal Income Trust (KTF) (the “Fund”) announced today its regular May monthly distribution.

Riskified Ltd. (NYSE: RSKD), a leader in ecommerce fraud and risk intelligence, today announced that its management team will participate virtually in the 21st Annual Needham Technology, Media, & Consumer 1×1 Conference on Thursday, May 14th, 2026.

The Board of Directors of Duff & Phelps Utility and Infrastructure Fund Inc. (NYSE: DPG), a closed-end fund advised by Duff & Phelps Investment Management Co., previously announced the following monthly distribution on March 16, 2026:

Hong Kong, May 08, 2026 (GLOBE NEWSWIRE) -- ICZOOM Group Inc. (Nasdaq: IZM) (the “Company”), a B2B electronic component products e-commerce platform, today announced that its board of directors has approved a change to the schedule of the Company’s previously announced extraordinary general meeting of shareholders (the “EGM”).

LOS ANGELES, CA / ACCESS Newswire / May 8, 2026 / Greenlite Ventures, Inc. (OTC:GRNL) today announced that legendary gaming entrepreneur Lyle Berman is investing in the company, bringing decades of industry-defining experience to support its next phase of growth.

The Board of Directors of DNP Select Income Fund Inc. (NYSE: DNP), a closed-end fund advised by Duff & Phelps Investment Management Co. (the “Adviser”), previously announced the following monthly distribution on March 16, 2026:

NEW YORK CITY, NY / ACCESS Newswire / May 8, 2026 / Stagwell Inc. (the "Company") announced today the grant of equity inducement awards. Effective May 7, 2026, the Company granted a total of 94,297 restricted stock units to five new employees. Each restricted stock unit represents the right to receive one share of the Company's Class A common stock. The restricted stock units will vest in two installments, with one-third vesting on the second anniversary of the grant date and two-thirds vesting on the third anniversary of the grant date. The restricted stock units are subject to accelerated vesting upon (i) termination of employment by the Company without Cause or (ii) death or disability. The Company granted these awards as a material inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4).

Capital One Financial Corporation (NYSE: COF) today announced a quarterly dividend of $0.80 per common share payable June 1, 2026, to stockholders of record at the close of business on May 19, 2026. The company has announced dividends on its common stock every quarter since it became an independent company on February 28, 1995. Dividends declared by the company are eligible for direct reinvestment in the company's common stock under its Dividend Reinvestment and Stock Purchase Plan. For additional Plan information, stockholders should contact Computershare Trust Company, N.A., at 1-888-985-2057 (inside the U.S. and Canada) or 1-781-575-2725 (outside the U.S. and Canada).

TruBridge, Inc. (NASDAQ: TBRG) (“TruBridge”), a leading provider of healthcare technology solutions for rural and community hospitals, today announced financial results for the first quarter ended March 31, 2026.

TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the “Company”), a leading provider of cloud-based software and integrated hardware solutions, today announced the appointment of Robert Campbell as Chief Financial Officer, effective upon the June 30, 2026, retirement of long-time Chief Financial Officer, Steven A. DeMartino.

Hawaiian Electric Industries, Inc. (NYSE - HE) (HEI) today reported net income for the first quarter of 2026 of $30 million, or $0.18 per share, compared to net income of $27 million, or $0.15 per share in the first quarter of 2025. Excluding Maui wildfire-related expenses and expenses taken in connection with the review of strategic options for Pacific Current, Core1 net income was $31 million, or $0.18 per share, compared to $40 million, or $0.23 per share in 2025.

Roku, Inc. (Nasdaq: ROKU) announced today that Chief Financial Officer and Chief Operating Officer Dan Jedda will participate in a fireside chat at the Needham Internet and Media Conference in New York City on Tuesday, May 12. Mr. Jedda is scheduled to appear at 1:30 PM ET.

BRISBANE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on May 4, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 40,250 shares of Class A common stock and restricted stock units (RSUs) underlying 20,125 shares of Class A common stock to ten (10) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

REGULATED INFORMATIONMay 8, 2026, 10:05pm CET / 4:05pm ET

BOCA RATON, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- James Cacioppo, Chief Executive Officer, Chairman, and Founder of Jushi Holdings Inc. (the "Company"), announced today that he has filed an early warning report on Form 62-103F1 in connection with his acquisition of subordinate voting shares of the Company ("Subordinate Voting Shares") on December 11, 2025.

-- With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices --

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted to ENDO2026 and ASBMR

JINHUA, China, May 08, 2026 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (“Kandi” or the “Company”) (NASDAQ GS: KNDI), a global innovator in intelligent equipment and a technology-driven platform company, today announced that, on May 5, 2026, the Company received a notification letter (“Nasdaq Notification”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement from March 23, 2026 through May 4, 2026. As set forth in the Nasdaq Listing Rules 5450(a)(1) (“Nasdaq Listing Rule”), it requires that the closing bid price for the Company’s ordinary shares listed on the Nasdaq be maintained at a minimum of $1.00 per share and failure to meet it for 30 consecutive business days constitutes a compliance deficiency.

Backblaze, Inc. (Nasdaq: BLZE), the high-performance cloud storage platform for the AI era, today announced participation in the following investor conference:

Sprouts Farmers Market, Inc. (Nasdaq: SFM), one of the largest and fastest-growing specialty retailers of fresh, natural and organic food in the United States, today announced the company’s participation in the 2026 BMO Global Farm to Market Conference in New York City. Jack Sinclair, chief executive officer, and Curtis Valentine, chief financial officer, are scheduled to conduct a fireside chat discussion at 11:00 a.m. Eastern Time on Wednesday, May 13, 2026.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Immutep (IMMP) To Contact Him Directly To Discuss Their Options

PALO ALTO, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that on May 6, 2026, the compensation committee of BridgeBio’s board of directors approved equity grants to 52 new employees in restricted stock units for an aggregate of 115,007 shares of the Company’s common stock. One-fourth of the shares underlying each employee’s restricted stock units will vest on May 16, 2027, with one-twelfth of the remaining shares underlying each such employee’s restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee’s continued employment with the Company or one of its subsidiaries on such vesting dates.

Baton Rouge, Louisiana - A federal court has ruled in favor of the insured client of J. Price McNamara, Disability, Life, AD&D Insurance Attorney in his ERI